Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


Market Overview:

The global intravenous solutions market size reached US$ 14.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

Intravenous (IV) solutions are supplemental fluids comprising water, electrolytes, sugar, and medications. They are given to patients according to their requirements, medical condition, age, and body size to restore fluid volume and treat electrolyte balance. At present, they are widely used in IV therapy to replace electrolyte losses, administer drugs and blood products, and supply essential nutrients to the intravascular fluid compartment.

Intravenous Solutions Market Trends:
Due to the sudden outbreak of coronavirus disease (COVID-19), there is a rise in the demand for IV solutions worldwide to provide essential nutrients to patients in the intensive care unit (ICU). Apart from this, the increasing number of people who have diabetes, cancer, gastrointestinal disorder, and neurological diseases represents another major growth-inducing factor. Moreover, the faster response time and higher efficacy associated with IV solution therapy is contributing to market growth. It is used to overcome chronic dehydration that can cause fatigue, memory problems, irritability, and other medical conditions. This, along with the increasing participation of individuals in physical activities, is influencing the adoption of IV solutions for a fast recovery. IV solutions are also utilized to improve skin conditions and treat migraines and hangovers. Besides this, leading manufacturers are introducing easy-to-use, portable product variants that can be used as drips at home. Additionally, due to rising environmental concerns, they are developing premixed solutions that reduce the amount of packaging waste. Furthermore, rising investments by health agencies of numerous countries in the healthcare sector are anticipated to create a favorable market outlook.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global intravenous solutions market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on type and nutrients.

Breakup by Type:

Partial Parenteral Nutrition
Total Parenteral Nutrition

Total parenteral nutrition is currently the most preferred type of IV solution as it helps prevent malnutrition and maintain energy.

Breakup by Nutrients:

Carbohydrates
Salts and Electrolytes
Minerals
Vitamins
Amino Acids

Breakup by Region:

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Presently, North America enjoys the leading position in the market due to the increasing prevalence of chronic diseases in the region.

Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Ajinomoto Co., Inc., B. Braun Melsungen AG, Baxter International, Inc., Grifols S.A., and Otsuka Pharmaceutical.

Key Questions Answered in This Report

1. What is the expected growth rate of the global intravenous solutions market during 2023-2028?
2. What are the key factors driving the global intravenous solutions market?
3. What has been the impact of COVID-19 on the global intravenous solutions market?
4. What is the breakup of the global intravenous solutions market based on the type?
5. What is the breakup of the global intravenous solutions market based on the nutrients?
6. What are the key regions in the global intravenous solutions market?
7. Who are the key players/companies in the global intravenous solutions market?


1 Preface
2 Scope and Methodology
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 Executive Summary
4 Introduction
4.1Overview
4.2Key Industry Trends
5 Global Intravenous Solutions Market
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Breakup by Type
5.5Market Breakup by Nutrients
5.6Market Breakup by Region
5.7Market Forecast
5.8SWOT Analysis
5.8.1Overview
5.8.2Strengths
5.8.3Weaknesses
5.8.4Opportunities
5.8.5Threats
5.9Value Chain Analysis
5.9.1Overview
5.9.2Research and Development
5.9.3Raw Material Procurement
5.9.4Manufacturing
5.9.5Marketing
5.9.6Distribution
5.9.7End-Use
5.10Porters Five Forces Analysis
5.10.1Overview
5.10.2Bargaining Power of Buyers
5.10.3Bargaining Power of Suppliers
5.10.4Degree of Competition
5.10.5Threat of New Entrants
5.10.6Threat of Substitutes
6 Market Breakup by Type
6.1Partial Parenteral Nutrition
6.1.1 Market Trends
6.1.2 Market Forecast
6.2Total Parenteral Nutrition
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Nutrients
7.1Carbohydrates
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Salts and Electrolytes
7.2.1 Market Trends
7.2.2 Market Forecast
7.3Minerals
7.3.1 Market Trends
7.3.2 Market Forecast
7.4Vitamins
7.4.1 Market Trends
7.4.2 Market Forecast
7.5Amino Acids
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Region
8.1North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5Latin America
8.5.1 Market Trends
8.5.2 Market Forecast
9 Intravenous Solutions Manufacturing Process
9.1Product Overview
9.2Raw Material Requirements
9.3Manufacturing Process
9.4Key Success and Risk Factors
10 Competitive Landscape
10.1Market Structure
10.2Key Players
10.3Profiles of Key Players
10.3.1Ajinomoto
10.3.1.1Company Overview
10.3.1.2Description
10.3.1.3Product Portfolio
10.3.1.4Financials
10.3.1.5SWOT Analysis
10.3.2B. Braun Melsungen
10.3.2.1Company Overview
10.3.2.2Description
10.3.2.3Product Portfolio
10.3.2.4Financials
10.3.2.5SWOT Analysis
10.3.3Baxter International Inc.
10.3.3.1Company Overview
10.3.3.2Description
10.3.3.3Product Portfolio
10.3.3.4Financials
10.3.3.5SWOT Analysis
10.3.4Grifols
10.3.4.1Company Overview
10.3.4.2Description
10.3.4.3Product Portfolio
10.3.4.4Financials
10.3.4.5SWOT Analysis
10.3.5Otsuka Pharmaceutical
10.3.5.1Company Overview
10.3.5.2Description
10.3.5.3Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings